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ABSTRACT 
Background 
Experimental models of pain in humans are crucial for understanding pain mechanisms. The most 
often used muscle pain models involve the injection of algesic substances, such as hypertonic saline 
solution or nerve growth factor, or the induction of delayed onset muscle soreness (DOMS) by an 
unaccustomed exercise routine. However, these models are either invasive or take substantial time 
to develop, and the elicited level of pain/soreness is difficult to control. To overcome these 
shortcomings, we propose to elicit muscle pain by a localized application of short-wave diathermy 
(SWD). 
Methods 
In this crossover study, SWD was administered to eighteen healthy volunteers to the wrist extensor 
muscle group, with a constant stimulation intensity and up to 4 minutes. Pressure pain threshold 
(PPT), pinprick sensitivity (PPS) and self-reported muscle soreness were assessed at baseline and at 
0, 30 and 60 minutes after application of SWD. 
Results 
SWD evoked localized muscle pain/soreness in the wrist extensor muscle group and a decrease of 
PPT in the treated arm compared with the control arm that lasted for at least 60 minutes, reflecting 
ongoing hyperalgesia after SWD application. PPS was not significantly altered 30 to 60 min following 
SWD, suggesting a minimal contribution from skin tissue to sustained hyperalgesia. 
Conclusions 
SWD was able to elicit muscle soreness and hyperalgesia up to 60 min after its application. Thus, this 
new model represents a promising tool for investigating muscle pain in humans. 
Key words (5 maximum): Short-wave diathermy, Experimental pain model, Hyperalgesia, 
Musculoskeletal pain 
 
INTRODUCTION 
Pain-related pathologies are associated with many concurrent physiological and psychophysical 
processes in patients, resulting in a large number of confounding factors in the evaluation of specific 
mechanisms behind pain (Raffaeli & Arnaudo, 2017). Thus, researchers have developed surrogate 
experimental pain models to be tested on healthy volunteers, facilitating the assessment of pain 
effects on the sensory-motor system (Graven-Nielsen, 2006; Le Bars et al., 2001). In general, 
experimental pain models should have the following desirable features: they should be established 
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in a short time, the stimuli that elicit pain should be reasonably controlled and the effects of the 
experiments should be fully reversible, short lasting and homogeneous across volunteers. However, 
to the best of our knowledge, there are no experimental pain models to date that fulfill all these 
conditions. 
Experimental pain models use different stimulus modalities to elicit pain, including mechanical (Nie 
et al., 2005; Staud et al., 2003), chemical (Babenko et al., 1999; Svensson et al., 2003), thermal (Meh 
& Denišlič, 1994; Miron et al., 1989) or electrical stimuli (Curatolo et al., 2001; Laursen et al., 1997; 
Neziri et al., 2011), among others. For acute muscle pain, one of the most widely used models 
involves the administration of intramuscular injection of algesic substances like hypertonic saline 
solution into the muscle itself or its surrounding areas (Graven-Nielsen et al., 1997; Mista et al., 
2015). These models require invasive procedures, elicit an uneven distribution of pain intensity and 
present a short time frames for the development and assessment of pain. Another commonly used 
model is delayed-onset muscle soreness (DOMS) elicited by unaccustomed eccentric exercise 
routine. DOMS has a slow development (24 to 48 h), the resulting level of pain/soreness is hard to 
control and depends on the subject’s training status (Proske & Morgan, 2001). Thus, although these 
models are widely used, their limitations uphold the development of new alternatives. 
An unexplored possibility is to elicit muscle pain by a localized application of short-wave diathermy 
(SWD). High frequency oscillations of non-ionizing electromagnetic fields in the radiofrequency (RF) 
range, around 27 MHz (short-wave), can heat deep tissues in a well-localized region (Draper et al., 
1999; Goats, 1989; Shields et al., 2002). Deep tissue heating by means of RF is a safe and extensively 
used technique in palliative treatment of pain and as a healing agent in soft tissues (Guo et al., 2012; 
Yu & Peng, 2017). However, SWD has not been previously explored with intensities suitable for 
inducing sustained muscle pain. 
The aim of the present study was to investigate whether SWD can elicit localized muscle 
pain/soreness on the wrist extensor muscle group. Pressure pain threshold (PPT), pinprick sensitivity 
(PPS) and self-reported muscle soreness were assessed in both the dominant and the non-dominant 
arm (acting as control) at baseline and at 0, 30 and 60 minutes after application of SWD, in order to 
test for long lasting effects. 
 
METHODS 
Participants 
Nineteen healthy volunteers (7 females and 12 males, age: 29 ± 5 years, weight: 69.3 ± 13.8 kg, 
height: 171.1 ± 10.4 cm, mean ± standard deviation) were recruited for the study. One volunteer was 
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excluded after reporting a previous surgery in the non-dominant arm. Volunteers had no history of 
pain or neuromuscular disorders affecting the upper limb region. All volunteers received written and 
verbal description of the procedures and gave written inform consent. The study was approved by 
the Central Bioethics Committee for Biomedical Practice and Research, dependent from the Ministry 
of Health of Entre Rios (identifier: IS001890). Study preregistration, including original hypothesis, 
description of primary and secondary outcomes, and initial sample size consideration, was done at 
ClinicalTrials.gov (identifier: NCT03573219) and the Declaration of Helsinki was respected.  
Sample size considerations 
Sample size was derived taking into account the expected effect size that the model will have on the 
primary outcome (PPT). Since there is no existing information on the expected size of the difference 
in PPT due to the application of SWD, this value was approximated taking into account reference 
values of differences in PPT generated by other experimental models of pain, such as the injection of 
hypertonic saline solution or DOMS. In these cases, PPT is usually reduced between 10 and 30% 
during the effects of the model, so an average reduction of 20% compared to baseline was 
considered. Taking into account a probability of making a type I error (α) of 5%, a statistical power (1 
- β) of 80%, and an estimated correlation between measures of 0.8, the sample size required to 
detect a decrease of 20% in PPT immediately after the administration of SWD was 16 volunteers. In 
order to account for an unexpectedly larger variation, 19 subjects were finally recruited.  
Short-wave diathermy  
SWD was administered using a CEC M-8 short-wave thermotherapy unit (CEC Electrónica S.R.L., 
Argentina) that delivers RF at a frequency of 27.12 MHz. The device has two rectangular capacitive 
applicators (18 x 12 cm), that were positioned below and above the dominant forearm, over the 
extensor carpi radialis brevis (ECRB) muscle. Coplanar application was performed using the 
continuous wave mode. SWD application has two main parameters that can be controlled: 
application time and stimulation intensity. It is clear that at least one of these parameters must be 
fixed to reduce the degrees of freedom of the model. During pilot experiments, we tested both 
possible configurations: fixed application time with variable stimulation intensity, and fixed 
stimulation intensity with variable application time. The most consistent results in terms of 
pain/soreness elicited after stimulation were obtained using a fixed stimulation intensity at a 
constant value (12 out of 20 on the thermotherapy unit scale) and applying SWD for as long as 
subjects could tolerate the stimulation (i.e. until subjects reached tolerance threshold for thermal 
pain), at which moment stimulation was immediately interrupted. In this way, we found that the 
selected intensity was adequate to develop sustained pain/soreness within a reasonable time frame. 
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Response profiles during SWD application 
A computerized, custom-made Visual Analog Scale (VAS) was used to continuously track the 
response profile to thermal stimuli across subjects during the application of SWD. The scale range 
was from 0 to 100, where 0 represents no perception, 30 represents the pain threshold (defined 
here as the time to reach a painful sensation at the predefined stimulation intensity) and 100 
represents the tolerance threshold (defined here as the time at which the pain sensation becomes 
intolerable). The scale was anchored according to response profiles observed during pilot 
experiments, in which the early parts of the response profiles were reported as clearly non-painful 
thermal sensations. Additionally, the first two parts of the McGill questionnaire (related to the 
location and quality of pain) were used to describe the sensation when tolerance threshold was 
reached (Melzack, 1975). 
Pressure pain threshold assessment 
Pressure pain thresholds (PPT) were assessed using a digital algometer (Somedic SenseLab AB, 
Sweden), directly over the ECRB muscle, using a 1 cm2 round tip. Pressure was gradually increased 
from 0 kPa at a rate of approximately 30 kPa/s (maximal achievable pressure: 2000 kPa). PPT was 
defined as the pressure at which the mechanical sensation becomes painful. The assessment was 
repeated three time for each arm, alternating sides between measurements. The median value of 
the three assessments was used for further analysis (Bergin et al., 2015; Neziri, Scaramozzino et al., 
2011). Changes in PPT are indicative of the development of mechanical hyperalgesia in the muscle. 
Pinprick assessment 
Pinprick stimuli were applied perpendicularly on the skin over the ECRB muscle using a pinprick 
stimulator, consisting on a needle with a 0.25 mm2 tip calibrated to a weight of 50 g. The stimulus 
was repeated three times for each arm, randomizing the order of assessment for each trial. 
Volunteers scored pinprick sensation on a Numerical Rating Scale (NRS), where 0 represents no 
perception, 30 represents the pain threshold, and 100 represents the tolerance threshold. Pinprick 
stimuli were assessed to differentiate deep-tissue from cutaneous hyperalgesia. 
Self-reported muscle pain/soreness  
A modified self-report Likert scale was used to follow the temporal progression of muscle 
pain/soreness at 0, 30, and 60 minutes after SWD, with 0 defining a complete absence of soreness 
and 6 indicating severe soreness (see Table 1 for a full description of the muscle soreness scores). 
This scale was selected based on previous studies reporting the effects of experimental muscle pain 
models (Andersen et al., 2008; Bergin et al., 2015). Additionally, self-assessment was repeated 24 h 
after the experiment, in order to check for potential longer lasting effects of SWD. 
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Experimental protocol 
Volunteers participated in a single experimental session. They were instructed to sit down 
comfortably with the arms extended and the palm in prone position. Baseline measures (PPT, PPS, 
and self-reported muscle pain/soreness) were performed at the beginning of the experiment. SWD 
was then applied to the wrist extensor muscle group of the dominant arm, due to its incidence and 
prevalence of dominance in clinical muscle pain (Vicenzino & Wright, 1996) (Fig. 1). Initially, low 
intensity SWD (4 out of 20 on the thermotherapy unit scale) was applied in order to localize the 
region to be treated without warming unwanted areas (such as wrist flexor muscles), according to 
verbal reports from the subjects. Afterwards, stimulation was stopped and restarted using the 
prefixed stimulation intensity (12 out of 20). Subjects were instructed to report the ongoing thermal 
sensation using the VAS scale during stimulation, until tolerance threshold for thermal pain was 
reached, stopping immediately after. PPT, PPS, and self-reported muscle pain/soreness were 
quantified immediately after SWD application, as well as 30 and 60 min later. The assessment was 
performed only three time points in order to avoid substantial habituation to mechanical 
stimulation. 
Data analysis and statistics 
Statistical analysis was performed using R v. 3.5.1 (R Core Team, 2018). A two-way repeated 
measures ANOVA with within-subject factors time (0, 30, 60 minutes after SWD) and arm (treated 
and control) was used to evaluate differences in PPT and PPS due to the application of SWD, 
calculated as percentage of change from baseline. Mauchly’s test was carried out to verify the 
assumption of sphericity, and the Greenhouse-Geisser correction was applied for PPS data. A non-
parametric Friedman test was employed to quantify the self-reported muscle pain/soreness after 
SWD with within-subject factor time (baseline and 0, 30, 60 minutes after SWD). Tukey’s post hoc 
tests (in its parametric and non-parametric versions) were carried out when appropriate. For model 
characterization purposes, Spearman's rank-order correlations (ρ) were calculated between the 
following variables: change in PPT, PPS and self-reported muscle pain/soreness at 0, 30 and 60 min, 
and time to reach tolerance threshold during SWD application. Values are reported as mean ± 
standard deviation or median [interquartile range] depending on whether the underlying data was 
normally distributed or not. P values smaller than 0.05 were regarded as statistically significant.  
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RESULTS 
Reported pain intensity and quality during SWD 
The induced muscle pain increased with different profiles for each subject, reaching the tolerance 
threshold in 1.59 [1.47] minutes (Fig. 2A). The resulting spatial extension of pain matched the 
treated forearm region (Fig. 2B). At the peak of the induced thermal muscle pain (i.e. at tolerance 
level), 22% of the participants described the pain as hot, 61% as burning, 11% as scalding, and the 
remaining 6% as searing.  
Self-reported muscle pain/soreness 
Subjects reported no muscle pain/soreness at baseline. A main effect of time was found for the self-
reported muscle pain/soreness scores (   = 19.441, P < 0.001). Post hoc tests showed that scores 
were significantly higher after SWD compared to baseline for all time points (P values ranging from < 
0.001 to 0.043), but they were not significantly different among them (P values ranging from 0.065 
to 0.945). None of the subjects reported muscle pain/soreness 24 h after the experiment (Fig. 3). 
Pressure pain thresholds  
Absolute values for PPT for all assessment time points are shown in Table 2. A main effect of arm 
was found for the PPT change scores (F1,17 = 8.897,   
  = 0.34, P = 0.008; Fig. 4). The treated arm 
showed a significant decrease of PPT values compared to the control arm at all time points (P = 
0.008), presenting an average difference of 13% between arms. No significant differences were 
neither found for time (F2,34 = 1.593,   
  = 0.086, P = 0.218) nor for the interaction (F2,34 = 0.042,   
  = 
0.002, P = 0.958). 
Pinprick sensitivity  
Absolute values for PPS for all assessment time points are shown in Table 2. Data from one subject 
was excluded from the pinprick sensitivity analysis as an outlier (the reported value was over three 
times larger than the standard deviation). No significant differences were found for arm (F1,17 = 
1.069,   
  = 0.059, P = 0.315) or time (F1.14,19.45 = 0.400,   
  = 0.031, P = 0.487). However, a significant 
interaction was found (F2,32 = 3.802,   
  = 0.192, P = 0.033; Fig. 5). The post-hoc analysis revealed that 
the treated arm showed a significant increase of the PPS compared with the control arm only 
immediately after SWD (P = 0.019).  
Correlations between model outcomes 
On a purely exploratory basis, we attempted to correlate the following variables: change in PPT, PPS 
and self-reported muscle pain/soreness at 0, 30 and 60 min, and time to reach tolerance threshold 
during SWD application. Besides the expected significant intra-modal correlations across time points, 
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no significant correlations were found between assessment modalities or between any given 
modality and the time to reach tolerance (P > 0.05 for all calculated Spearman’s ρ).   
 
DISCUSSION  
Response profile during SWD application 
Volunteers reported a rapid increase in thermal pain during SWD application, reaching the heat 
tolerance threshold in a couple of minutes in most cases. This behavior is likely associated with 
responses from polymodal afferent fibers that act as heat-sensitive receptors. The transduction of 
the thermal stimulus is performed by a subset of channel receptors within the muscle afferents that 
sense and signal within specific temperature ranges. These receptors, including the temperature-
activated transient receptors (TRPV), not only detect temperature in innocuous range but also in the 
nociceptive range (Patapoutian et al., 2003). Once the thermal stimulus is transduced, group IV and, 
in less proportion, group III afferent fibers are associated with the transmission of the thermal 
stimulus from the muscle to the central nervous system (Graven-Nielsen et al., 2002; Raja et al., 
2018). Although the temperature inside the muscle was not measured during the SWD, it is known 
that temperatures over 43 °C are very uncomfortable for humans (Draper et al., 2004). Therefore, 
even though it is hypothesized that the temperature inside the muscle was above 43 °C before the 
stimulation was stopped, application timespans of a few minutes (max. 4 min for this experiment) 
are not enough to induce permanent thermal damage on the muscle tissue (Ichinoseki-Sekine et al., 
2007; Yarmolenko et al., 2011). 
Mechanisms associated with hyperalgesia induced by SWD 
Subjects reported muscle soreness and a decrease in PPT values immediately after SWD application 
compared to the control arm, that lasted for at least 60 min after the intervention, reflecting 
hyperalgesia in the treated region. It should be noted that five subjects showed a slight increase in 
PPT after SWD application. In all cases, however, the increase in PPT in the control arm was larger, 
probably reflecting habituation to mechanical stimulation, so the net difference between arms still 
showed an overall effect of SWD. Furthermore, four subjects did not report muscle soreness at any 
time point after SWD, although cross-referencing the data showed that all subjects but one showed 
a decrease in PPT.  
The observed effect is most likely due to an inflammatory response of the neuromuscular system 
triggered by a fast temperature increase in the muscle, coupled with an incapability of the 
musculoskeletal tissue to dissipate heat at the same speed, resulting in the release of algesic 
substances and/or local tissue damage. However, further studies assessing inflammatory markers 
are required in order to confirm an ongoing inflammatory process and to gain deeper understanding 
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of the model effects in the muscle, since most inflammatory pain models are related to skin (Kilo et 
al., 1994; Pedersen & Kehlet, 1998; Sandkühler, 2009; Treede et al., 1992). In this regard, it is worth 
mentioning that although hyperalgesia has been observed when inducing thermal pain in skin tissue 
(Pedersen & Kehlet, 1998), PPS after SWD only hinted at short-lasting changes after application in 
the present study, suggesting that the contribution of the skin to ongoing hyperalgesia after a few 
minutes is minimal.  
Several mechanisms may be involved in the initiation and prolongation of the inflammation in 
response to SWD. Among these mechanisms, neurogenic inflammation could account for the rapid 
development of hyperalgesia. This inflammation process is triggered by the axon reflex, which 
causes a release of pro-inflammatory neuropeptides from the afferent fibers (Chiu et al., 2012; 
Meggs, 1993). Different substances are involved in the process, including substance P and calcitonin 
gene-related peptide that are released both peripherally as well as in the dorsal spinal cord 
(Richardson & Vasko, 2002). These substances mediate neurogenic inflammation symptoms by 
interacting with muscular and connective tissue cells (Campos & Calixto, 2000). Another pathway 
that may be associated with the observed hyperalgesia is the release of pro-inflammatory 
substances by the musculoskeletal tissue itself (Welc et al., 2013). For instance, interleukin-6 (IL-6) 
might be particularly relevant, since it has been previously demonstrated that it is highly 
upregulated following a significant increase of heat in the muscle (Welc et al., 2013; Welc et al., 
2013). This pro-inflammatory cytokine is synthesized in the initial stage of inflammation, and has 
also been suggested to play a role in the process of pathological pain (Tanaka et al., 2014; Zhang & 
An, 2007).  
As mentioned before, mechanical hyperalgesia observed after SWD is presumably associated with 
the described peripheral responses at the beginning of the process. Nevertheless, central 
mechanisms cannot be excluded as a contributing modulatory factor. There is strong evidence that 
acute peripheral inflammation involves specific central mechanisms, for example, through 
hyperexcitability of dorsal horn nociceptive neurons (Andrew & Greenspan, 1999; Schaible, 2007; 
Treede et al., 1992) and through changes in the release of inflammatory mediators or vasodilation by 
the sympathetic and parasympathetic system (Waldburger & Firestein, 2010). In rats, subcutaneous 
inflammation causes an increase of spinal glia activity, constituting a direct evidence of a central 
change induced by an acute stimulation (Sweitzer et al., 1999). In human experimental inflammation 
of the skin, it has been suggested that central excitability remains increased once triggered even 
after a single stimulation, and it does not require an ongoing nociceptive input (Kilo et al., 1994). 
However, the contribution of central mechanisms to hyperalgesia remains unclear, and further 
studies are needed to elucidate the processes involved in muscle inflammation after SWD.  
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SWD as a muscle pain model 
The experimental pain model presented in this study has several key features. First, it is based on an 
exogenous stimulation technique that does not require invasive procedures, unlike intramuscular 
injection of algesic substances that are invasive and demand additional precautions when used, 
including correct asepsis, the use of sterile and disposable substances, and experience in the 
injection technique to avoid damage to nerves or other structures (Bergin et al., 2015; Thomas 
Graven-Nielsen et al., 2001; Sjøogaard et al., 2000). In addition, the hyperalgesia observed after the 
stimulation presented similar profiles compared to those reported in longer-lasting muscle pain 
models using nerve growth factor (NGF) or DOMS, but without requiring a long development time 
(Bergin et al., 2015; Hedayatpour et al., 2008). Furthermore, muscle exercise induced pain triggers 
the release of algesic substances, including cytokinin and NGF, resulting in hyperalgesia and 
movement evoked pain for at least 24-48 hours after the intervention (Bergin et al., 2015; Murase et 
al., 2010; Tegeder et al., 2002). This does not correspond with the findings presented here using 
SWD, where there was an absence of discomfort or movement evoked pain when assessed after 24 
h. In terms of the scientific and ecological validity of the model, it is worth stressing that even 
though the stimulus used to induce pain is thermal, the duration and nature of the effects observed 
suggest that the physiological mechanisms responsible for maintaining pain/soreness are of 
inflammatory origin. Finally, it should be noted that our goal is not to replace or criticize existing 
muscle pain/soreness models, but to develop an alternative or complementary model that is non-
invasive and can be easily applied using inexpensive equipment commonly used for physical therapy, 
in which the stimulation parameters can be readily controlled. Furthermore, the model has a rapid 
development time and a reasonable duration, and was successfully established in almost all 
volunteers tested, which suggests good reliability. 
Limitations and future work 
Given the fact that there is no previous investigation about SWD as a pain model, the parameters of 
the stimulation were set after pilot experiments, and hence further work is required to fully describe 
the effects of changes in the parameters (e.g. SWD intensity, application time, type of applicator) in 
the model outcome. As described in the pre-registered protocol, we aimed at a 20% change in PPT 
compared to baseline, and the observed effect was slightly smaller (still detected likely due to the 
effect lasting longer than anticipated). Thus, we hypothesize that a larger and more homogeneous 
effect can be achieved using different parameters, for example using a higher stimulation intensity 
or by rekindling, since the observed PPT variability was still relatively high. In addition, it might be 
argued that PPT or PPS stimulate both skin and muscle, but changes in PPT and PPS did not show any 
significant correlation. Furthermore, it has been shown that the pinprick threshold is increased 
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whereas PPT values are not affected when the skin in anesthetized (Graven-Nielsen et al., 2004). 
Additionally, muscle tissue subjected to a sustained temperature of 42 °C over 30 minutes showed 
not effect in the force exerted in rats, although it drastically affected the contractile properties of 
the muscle, reducing tetanic and peak twitch tension (Locke & Celotti, 2014). Therefore, studies 
assessing muscle control and function during movement or a force task may have to take the 
changes in contractile properties into consideration in their conclusions. Finally, further experiments 
are required in order to confirm the physiological mechanisms behind the model, in order to better 
associate it with mechanisms found in physiopathological conditions. 
 
CONCLUSION 
This new model based on SWD represents a promising tool for investigating muscle pain/soreness in 
humans. The main advantages of the model are its non-invasiveness, the ability to control 
stimulation parameters, and the convenience of the time frame in which pain and hyperalgesia are 
developed.  
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FIGURE LEGENDS 
Fig. 1. (a) Short wave diathermy (SWD) was applied to the forearm until tolerance threshold was 
reached, while volunteers reported the response profile of thermal stimuli using an Analog Visual 
Scale (VAS). (b) Experimental procedure. Pressure pain threshold (PPT) and pinprick (PPS) were first 
measured at baseline. Afterwards, SWD was administered to the dominant forearm. A self-reported 
muscle pain/soreness assessment of the model effects was carried out, then PPT and PPS 
assessment was repeated after 0, 30, and 60 min. 
 
Fig. 2. (a) Time course of the reported thermal induced muscle pain during SWD (0 represents the 
beginning of the stimulation), it can be noted that tolerance thermal threshold was reached with 
different speed across subjects. (b) pain chart drawings of the painful area at the tolerance threshold 
in the treated arm. 
 
Fig. 3. Self-reported muscle soreness scores of the treated arm at baseline, 0, 30, 60 min, and 24 hs 
(see Table 1 for a description of the soreness scores).  
 
Fig. 4. Individual (light numbered lines) and average (heavy line) PPT from control (left) and treated 
(right) arms at 0, 30, 60 minutes after intervention. Values are presented as percentage of change 
from baseline -i.e. before SWD. ** Treated arm showed a significant decrease in PPT compared with 
control arm for all time points (P = 0.008). 
 
Fig. 5. Individual (light numbered lines) and average (heavy line) PPS scores from treated and control 
arm at 0, 30, 60 minutes after application of SWD. Values are presented as percentage of change 
from baseline -i.e. before SWD. * Treated arm showed a significant increase of the PPS compared 
with the control arm only immediately after SWD (P = 0.019). 
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TABLE LEGENDS 
Table 1. Modified Likert scale of muscle pain/soreness. 
Table 2. Absolute values for pressure pain thresholds (PPT) and pinprick sensitivity (PPS) before, 
immediately after, and 30 and 60 min after administration of short-wave diathermy (SWD). 
 
 
 
Score Description 
0 a complete absence of soreness 
1 a light soreness in the muscle felt only when touched/a vague ache 
2 a moderate soreness felt only when touched/a slight persistent ache 
3 a light muscle soreness when lifting objects or carrying objects 
4 a light muscle soreness, stiffness or weakness when moving the wrist without 
gripping an object 
5 a moderate muscle soreness, stiffness or weakness when moving the wrist 
6 a severe muscle soreness, stiffness or weakness that limits my ability to move 
 
 
 
 Baseline 0 min 30 min 60 min 
PPT Treated 177.61 ± 83.03 
 
151.39 ± 66.43 
 
148.55 ± 64.42 
 
156.28 ± 58.35 
 
Control 164.33 ± 64.50 
 
166.44 ± 78.76 
 
162.44 ± 72.56 
 
176.44 ± 92.29 
 
PPS Treated 30.83 ± 16.11 
 
38.05 ± 16.64 
 
36.11 ± 18.27 
 
34.17 ± 16.38 
 
Control 29.83 ± 14.03 30.67 ± 14.36 
 
31.67 ± 14.55 
 
33.61 ± 14.53 
 
 
  
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
 
 
 
 
 
 
 
  
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
  
A
cc
ep
te
d
 A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
